Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lauri E Markowitz

Showing results (121-130 of 290) with videos related to

Pageof 29
Sort By:
Emerging Infectious Diseases|November 21, 2017
CDC Activities for Improving Implementation of Human Papillomavirus Vaccination, Cervical Cancer Screening, and Surveillance WorldwideVirginia Senkomago, Denise Duran, Anagha Loharikar, et al.
Vaccine|March 12, 2023
Updated estimate of the annual direct medical cost of screening and treatment for human papillomavirus associated disease in the United StatesPatrick A Clay, Trevor D Thompson, Lauri E Markowitz, et al.
Human Vaccines & Immunotherapeutics|February 19, 2024
High impact of quadrivalent human papillomavirus vaccine across racial/ethnic groups: National Health and Nutrition Examination Survey, 2003-2006 and 2015-2018Ruth Stefanos, Rayleen M Lewis, Troy D Querec, et al.
The Journal of Infectious Diseases|February 8, 2017
Prevalence of Genital Human Papillomavirus in Males, United States, 2013-2014Julia W Gargano, Elizabeth R Unger, Gui Liu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 19, 2021
An Evaluation of Dose-Related HPV Vaccine Effectiveness Using Central Registries in MichiganJulia W Gargano, Mei You, Rachel Potter, et al.
Sexually Transmitted Diseases|June 23, 2025
Association between high-risk HPV prevalence and circumcision status among sexually experienced adult males, 2013-2016, United StatesRayleen M Lewis, Sarah K Brewer, Julia W Gargano, et al.
Annals of Internal Medicine|May 16, 2022
Human Papillomavirus Vaccine Impact and Effectiveness Through 12 Years After Vaccine Introduction in the United States, 2003 to 2018Hannah G Rosenblum, Rayleen M Lewis, Julia W Gargano, et al.
MMWR. Morbidity and Mortality Weekly Report|August 24, 2018
Trends in Human Papillomavirus-Associated Cancers - United States, 1999-2015Elizabeth A Van Dyne, S Jane Henley, Mona Saraiya, et al.
MMWR. Morbidity and Mortality Weekly Report|March 25, 2021
Declines in Prevalence of Human Papillomavirus Vaccine-Type Infection Among Females after Introduction of Vaccine - United States, 2003-2018Hannah G Rosenblum, Rayleen M Lewis, Julia W Gargano, et al.
Sexually Transmitted Diseases|October 12, 2013
Expedited partner therapy in federally qualified health centers--New York City, 2012Camille E Introcaso, Meighan E Rogers, Sharon A Abbott, et al.
Pageof 29

Showing results (121-130 of 290) with videos related to

Sort By:
Pageof 29
Emerging Infectious Diseases|November 21, 2017
CDC Activities for Improving Implementation of Human Papillomavirus Vaccination, Cervical Cancer Screening, and Surveillance WorldwideVirginia Senkomago, Denise Duran, Anagha Loharikar, et al.
Vaccine|March 12, 2023
Updated estimate of the annual direct medical cost of screening and treatment for human papillomavirus associated disease in the United StatesPatrick A Clay, Trevor D Thompson, Lauri E Markowitz, et al.
Human Vaccines & Immunotherapeutics|February 19, 2024
High impact of quadrivalent human papillomavirus vaccine across racial/ethnic groups: National Health and Nutrition Examination Survey, 2003-2006 and 2015-2018Ruth Stefanos, Rayleen M Lewis, Troy D Querec, et al.
The Journal of Infectious Diseases|February 8, 2017
Prevalence of Genital Human Papillomavirus in Males, United States, 2013-2014Julia W Gargano, Elizabeth R Unger, Gui Liu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 19, 2021
An Evaluation of Dose-Related HPV Vaccine Effectiveness Using Central Registries in MichiganJulia W Gargano, Mei You, Rachel Potter, et al.
Sexually Transmitted Diseases|June 23, 2025
Association between high-risk HPV prevalence and circumcision status among sexually experienced adult males, 2013-2016, United StatesRayleen M Lewis, Sarah K Brewer, Julia W Gargano, et al.
Annals of Internal Medicine|May 16, 2022
Human Papillomavirus Vaccine Impact and Effectiveness Through 12 Years After Vaccine Introduction in the United States, 2003 to 2018Hannah G Rosenblum, Rayleen M Lewis, Julia W Gargano, et al.
MMWR. Morbidity and Mortality Weekly Report|August 24, 2018
Trends in Human Papillomavirus-Associated Cancers - United States, 1999-2015Elizabeth A Van Dyne, S Jane Henley, Mona Saraiya, et al.
MMWR. Morbidity and Mortality Weekly Report|March 25, 2021
Declines in Prevalence of Human Papillomavirus Vaccine-Type Infection Among Females after Introduction of Vaccine - United States, 2003-2018Hannah G Rosenblum, Rayleen M Lewis, Julia W Gargano, et al.
Sexually Transmitted Diseases|October 12, 2013
Expedited partner therapy in federally qualified health centers--New York City, 2012Camille E Introcaso, Meighan E Rogers, Sharon A Abbott, et al.
Pageof 29